Navigation Links
PhRMA Statement on AARP-White House Press Conference
Date:6/22/2009

WASHINGTON, June 22 /PRNewswire-USNewswire/ -- Pharmaceutical Research and Manufacturers of America (PhRMA) President & CEO Billy Tauzin today issued the following statement regarding today's AARP-White House press conference on health care reform:

"With the strong support of AARP, we believe this agreement will be looked back in time as a momentum changer in the legislative efforts to reform our troubled health care system. Our $80 billion pledge toward that goal represents a huge financial commitment by America's pharmaceutical research and biotechnology companies. But we have a shared vision: every single person in America, regardless of their income, should have access to affordable, high-quality health care coverage and services.

"Even though we have had policy disagreements in the past, this is an historic coming-together moment. AARP, the largest advocacy organization on behalf of American seniors, clearly recognizes the importance of innovative, cutting-edge medicines to the lives of patients everywhere.

"And we recognize that a medicine which sits on a shelf out of reach of patients financially doesn't do anyone any good. Working together with President Obama, Senate Finance Committee Chairman Baucus and other congressional leaders, we have now taken an important first step toward achieving comprehensive health care reform this year.

"In life, we get precious few opportunities to fundamentally improve the lives of people all across our great nation. We are proud to join AARP, the White House and Congress in seizing that moment today."

The Pharmaceutical Research and Manufacturers of America (PhRMA) represents the country's leading pharmaceutical research and biotechnology companies, which are devoted to inventing medicines that allow patients to live longer, healthier, and more productive lives. PhRMA companies are leading the way in the search for new cures. PhRMA members alone invested an estimated $50.3 billion in 2008 in discovering and developing new medicines. Industry-wide research and investment reached a record $65.2 billion in 2008.

PhRMA Internet Address: http://www.phrma.org

For information on stories of hope and survival, visit: http://sharingmiracles.com/

For information on how innovative medicines save lives, visit: http://www.innovation.org

For information on the Partnership for Prescription Assistance, visit: http://www.pparx.org

For more information on public health emergencies, visit http://www.rxresponse.org

For information on the danger of imported drugs, visit: http://www.buysafedrugs.info


'/>"/>
SOURCE Pharmaceutical Research and Manufacturers of America
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. EMD Serono to Adopt Revised and Strengthened PhRMA Code
2. Informed Medical Communications Highlights Opportunity in Revised PhRMA Code
3. PhRMA, Families USA Jointly Promote Measures to Ensure Quality, Affordable Healthcare Coverage
4. VaxGen Files 2006 Financial Statements and Provides Cash Update
5. ARYx Therapeutics, Inc. Files Registration Statement for Initial Public Offering
6. Anacor Files Registration Statement for Initial Public Offering
7. IsoTis Files Definitive Proxy Statement
8. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
9. Statement on Direct-To-Consumer Genetic Testing
10. Coherent Announces Restatement Related to Stock-Based Compensation
11. XTL Biopharmaceuticals: AGM/EGM Statements
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... May 23, 2017 , ... Genedata, a ... anniversary, marking the occasion with a strong presence at Bio-IT World Conference & ... further extends an invitation to all attendees to view posters on the ...
(Date:5/23/2017)... ... May 23, 2017 , ... ... Vice President of Clinical Operations. She brings years of expertise in establishing and ... her professional foundation as a licensed occupational therapist, through a variety of leadership ...
(Date:5/22/2017)... , ... May 22, 2017 , ... ... with other leaders of the Maryland Biohealth community in developing and issuing recommendations ... Top 3 U.S. BioHealth Innovation Hub by 2023. , The ...
(Date:5/19/2017)... ... May 19, 2017 , ... ... Program. Academic researchers with technologies ripe for commercialization, and who are affiliated ... Delaware, are encouraged to submit proposals. QED, now in its tenth round, is ...
Breaking Biology Technology:
(Date:5/16/2017)... 16, 2017  Veratad Technologies, LLC ( www.veratad.com ), ... and identity verification solutions, announced today they will participate ... May 15 thru May 17, 2017, in ... Trade Center. Identity impacts the lives ... today,s quickly evolving digital world, defining identity is critical ...
(Date:4/24/2017)... , April 24, 2017 ... and partner with  Identity Strategy Partners, LLP (IdSP) ... "With or without President Trump,s March 6, 2017 ... Terrorist Entry , refugee vetting can be instilled with ... resettlement. (Right now, all refugee applications are suspended ...
(Date:4/17/2017)... 2017 NXT-ID, Inc. (NASDAQ: NXTD ) ... of its 2016 Annual Report on Form 10-K on Thursday April ... ... in the Investor Relations section of the Company,s website at ... at http://www.sec.gov . 2016 Year Highlights: ...
Breaking Biology News(10 mins):